This content is promotional.
The mAbXmise quantification kits are intended to monitor the concentration of therapeutic monoclonal antibodies (mAbs) in samples from patients treated with these mAbs. The kit is a quantitative assay. The test can be performed on plasma (EDTA, heparin or citrate collection tubes) and serum. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product.
This space contains information on medical devices, the use of which is reserved for healthcare professionals. In application of the law of December 29, 2011 relating to the strengthening of health security, I certify that I am a health professional and therefore be authorized to access this information.
mAbXmise monoclonal antibodies quantification kits are In Vitro Diagnostic Medical Devices for laboratory professional use and CE-IVD labeled for Europe by BSI. Assay results are intended to be used by healthcare professionals. The kits are designed to perform absolute quantification by LC-MS (Liquid Chromatography – Mass spectrometry) of specific therapeutic monoclonal antibodies (mAbs) in a patient sample. Assay results are intended to be used by healthcare professionals. Before use, it is important to carefully read the instructions provided with the product. The products are non-refundable. The mAbXmise Kit described has not been cleared by any regulatory entity for diagnostic purposes outside of Europe. Proteomics mAbXmise Kits are not available for sale in all countries.
I am a healthcare professional
Close window if you are not a healthcare professional
PROMISE Proteomics has developed a range of solutions to address the needs of bioanalytical scientists. Our stable-isotopically-labelled proteins (SIL-Proteins) and mAbs (SIL-mAbs) are used as internal standards in quantification assays. They are produced in our ISO9001 certified facility in Grenoble, France.
Our SIL-products are produced in dedicated expression systems with protocols specifically developed and optimized by PROMISE Proteomics team to ensure high isotopic incorporation, (>98%), high purity (>95%) and stability.
We propose also a range of ready-to-use kits, including our SIL-mAbs, which should facilitate and speed-up the implementation of LC-MS quantitative assays targeting mAbs in your lab. To learn more on this range, please visit our dedicated website www.mabxmise.com
Your SIL-protein or SIL-mAb of interest is not listed ? Promise Proteomics offers customized bioproduction options.
7, parvis Louis Néel • BHT 52 A • CS 20050
38040 Grenoble Cedex 9 • FRANCE
PHONE: +33 4 38 02 36 50